Form 4: BioAtla CFO Richard Waldron Acquires 100,000 Shares of Common Stock Through RSU Award
SEC Form 4 Filing
Richard Waldron, CFO of BioAtla, Inc., acquired 100,000 shares of common stock through a restricted stock unit (RSU) award that vests over time.
Summary
- On March 11, 2025, Richard A. Waldron, the Chief Financial Officer of BioAtla, Inc. (BCAB), acquired 100,000 shares of common stock.
- The acquisition was through a time-based restricted stock unit (RSU) award.
- The RSU will vest as to 25% of the total number of shares on March 11, 2026.
- Thereafter, 6.25% of the total number of shares subject to the RSU shall vest on the last day of each May, August, November and February, provided the reporting person remains a service provider.
- Following the transaction, Waldron directly owns 333,263 shares of BioAtla common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects a standard executive compensation practice (RSU grant) which aligns the CFO's interests with the company's performance. The vesting schedule encourages long-term commitment.
Positives
- The acquisition of shares by the CFO could be seen as a positive signal, indicating confidence in the company's future prospects.
Future Outlook
The RSU award vests over time, contingent on the reporting person remaining a service provider, suggesting continued employment and alignment with the company's long-term success.
Industry Context
Form 4 filings are standard disclosures for company insiders and provide transparency into their transactions in the company's stock. This particular filing indicates an equity-based compensation arrangement for the CFO, which is a common practice in the biotech industry to align management's interests with those of shareholders.
Comparison to Industry Standards
- RSU grants are a common form of executive compensation in the biotechnology industry.
- Companies like Amgen, Gilead, and Regeneron also utilize RSUs as part of their compensation packages to attract and retain key personnel.
- The vesting schedule of 25% after one year followed by quarterly vesting is fairly standard.
Stakeholder Impact
- Shareholders may view the RSU grant as a positive sign of management's commitment to the company.
- Employees may see this as a standard compensation practice for executives.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of transaction: Richard Waldron acquired 100,000 shares of common stock through an RSU award. |
| 03/11/2026 | First vesting date: 25% of the RSU shares will vest. |
| May, August, November, February | Quarterly vesting dates: 6.25% of the RSU shares will vest on the last day of each of these months, starting after the initial vesting date. |
| 03/13/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.